Stablecoin Development Corporation Company Profile
NYSE: SDEVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 1.98 -0.52%
Stablecoin Development at a glance
Stablecoin Development Corporation (NYSE: SDEV) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in EmeryVille, CA. Stablecoin Development is led by Mr. Michael John Kazley and employs about 2 people. At a market capitalization of $103.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001389545, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Stablecoin Development do?
Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoin Development Corporation in April 2026. Stablecoin Development Corporation was incorporated in 2000 and is headquartered in Emeryville, California.
Business description based on the company's public filings.
Company information
- Legal name
- Stablecoin Development Corporation
- Ticker
- NYSE: SDEV
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Michael John Kazley
- Employees
- 2
- Headquarters
- 2000 Powell Street, EmeryVille, CA, United States
- Phone
- 510 899 8800
- Website
- stabledev.com
- Market cap
- $102.99M
- SEC CIK
- 0001389545
Companies similar to Stablecoin Development
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AARDAardvark Therapeutics Inc. | 4.71 | -5.04% | $103.08M | vs SDEV |
| IMUXImmunic Inc. | 7.56 | -0.92% | $103.15M | vs SDEV |
| CRBPCorbus Pharmaceuticals Holdings Inc. | 5.27 | -4.01% | $101.93M | vs SDEV |
| CPIXCumberland Pharmaceuticals Inc. | 6.98 | +1.31% | $104.58M | vs SDEV |
| ANIXAnixa Biosciences Inc. | 2.91 | -1.36% | $101.16M | vs SDEV |
| KZIAKazia Therapeutics Limited ADR | 8.82 | -5.06% | $100.79M | vs SDEV |
| PLYXPolaryx Therapeutics Inc. | 2.00 | -4.31% | $99.69M | vs SDEV |
| BMEABiomea Fusion Inc. | 1.37 | +3.79% | $99.05M | vs SDEV |